Apeloa Pharmaceutical Co., Ltd.

Apeloa Pharmaceutical Co., Ltd. saw a significant rise in its stock on March 11, 2026, with an intraday high of CNY 18.83. Despite recent gains, the company faces challenges, including a 14.55% decline in net sales and a lower annual stock return compared to the China Shanghai Composite.

Apeloa Pharmaceutical Co., Ltd. experienced notable trading activity on March 6, 2026, with an intraday high of CNY 17.80. Despite a recent uptick, the company has faced challenges, including a decline in net sales and negative quarterly results, while its one-year performance lags behind the broader market.

Apeloa Pharmaceutical Co., Ltd. faced a significant stock decline, dropping 4.82% on October 22, 2025, and showing a 7.82% decrease over the month. Despite a market capitalization of CNY 18,513 million and a dividend yield of 4.48%, its long-term growth prospects remain limited.

Apeloa Pharmaceutical Co., Ltd. experienced notable stock activity on September 25, 2025, reaching an intraday high of CNY 16.96. The company has a market capitalization of CNY 18,513 million, a P/E ratio of 19.00, and a dividend yield of 4.48%, reflecting solid financial metrics.